Skip to main content
Top
Published in: Surgical Endoscopy 5/2016

01-05-2016

Non-alcoholic fatty liver disease resolution following sleeve gastrectomy

Authors: Ardeshir Algooneh, Sulaiman Almazeedi, Salman Al-Sabah, Maha Ahmed, Feras Othman

Published in: Surgical Endoscopy | Issue 5/2016

Login to get access

Abstract

Background

Non-alcoholic fatty liver disease (NAFLD), a disease highly prevalent among the morbidly obese population, is one of the most common causes of chronic liver disease today. The purpose of this study was to observe the effect of laparoscopic sleeve gastrectomy (LSG) on the resolution of NAFLD.

Methods

A retrospective study was conducted of 84 patients diagnosed with NAFLD prior to undergoing LSG. The diagnosis of NAFLD was achieved based on transabdominal ultrasonographic imaging as per the 2012 joint guidelines for the diagnosis of NAFLD (American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology). The patients had follow-up anthropometric measurements and were re-evaluated with postoperative ultrasounds at different time frames to assess the resolution of the disease.

Results

The median age of the patients was 44 (17–62), and 66.7 % were female. Average time since surgery was 3.3 years (range 1–5 years). The mean pre- and postoperative BMIs were 46.6 ± 7.8 and 33.0 ± 7.1, respectively, with a mean percent excess weight loss (%EWL) of 55.7 % ± 23.0. A total of 47 (56 %) patients showed complete resolution of NAFLD postoperatively. Multivariate analysis showed a significant resolution of NAFLD in patients achieving >50 % EWL (OR 10.1; p < 0.001) after controlling for age and sex.

Conclusions

Weight loss after LSG effectively resolved NAFLD in more than half of the obese patients in this study and can prove to be a useful tool in tackling the disease in the future.
Literature
2.
go back to reference Angulo P (2007) GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 25:883–889CrossRefPubMed Angulo P (2007) GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 25:883–889CrossRefPubMed
4.
go back to reference Oh M, Winn J, Poordad F (2008) Review article: diagnosis and treatment of nonalcoholic fatty liver disease. Aliment Pharmacol Ther 28(5):503–522CrossRefPubMed Oh M, Winn J, Poordad F (2008) Review article: diagnosis and treatment of nonalcoholic fatty liver disease. Aliment Pharmacol Ther 28(5):503–522CrossRefPubMed
5.
go back to reference Vernon G, Baranova A, Younossi Z (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–285CrossRefPubMed Vernon G, Baranova A, Younossi Z (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–285CrossRefPubMed
6.
go back to reference Day C (2011) Non-alcoholic fatty liver disease: a massive problem. Clin Med 11:176–178CrossRef Day C (2011) Non-alcoholic fatty liver disease: a massive problem. Clin Med 11:176–178CrossRef
7.
go back to reference Zelber-Sagi S, Ratziu V, Oren R (2011) Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol 17:3377–3389CrossRefPubMedPubMedCentral Zelber-Sagi S, Ratziu V, Oren R (2011) Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol 17:3377–3389CrossRefPubMedPubMedCentral
8.
go back to reference Adams L, Feldstein A (2010) Nonalcoholic steatohepatitis: risk factors and diagnosis. Expert Rev Gastroenterol Hepatol 4:623–635CrossRefPubMed Adams L, Feldstein A (2010) Nonalcoholic steatohepatitis: risk factors and diagnosis. Expert Rev Gastroenterol Hepatol 4:623–635CrossRefPubMed
9.
go back to reference Lonardo A, Lombardini S, Ricchi M et al (2005) Review article: hepatic steatosis and insulin resistance. Aliment Pharmacol Ther 22(Suppl. 2):64–70CrossRefPubMed Lonardo A, Lombardini S, Ricchi M et al (2005) Review article: hepatic steatosis and insulin resistance. Aliment Pharmacol Ther 22(Suppl. 2):64–70CrossRefPubMed
10.
go back to reference Krawczyk M, Bonfrate L, Portincasa P (2010) Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 24:695–708CrossRefPubMed Krawczyk M, Bonfrate L, Portincasa P (2010) Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 24:695–708CrossRefPubMed
11.
go back to reference Lonardo A, Bellentani S, Ratziu V et al (2011) Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient—death of a dogma from analysis of therapeutic studies? Expert Rev Gastroenterol Hepatol 5:279–289CrossRefPubMed Lonardo A, Bellentani S, Ratziu V et al (2011) Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient—death of a dogma from analysis of therapeutic studies? Expert Rev Gastroenterol Hepatol 5:279–289CrossRefPubMed
15.
go back to reference Chalasani N, Younossi Z, Lavine J et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55(6):2005–2023CrossRefPubMed Chalasani N, Younossi Z, Lavine J et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55(6):2005–2023CrossRefPubMed
16.
go back to reference Johnson B, Blackhurst D, Latham B et al (2013) Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg 216(4):545–556; discussion 556–558 Johnson B, Blackhurst D, Latham B et al (2013) Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg 216(4):545–556; discussion 556–558
17.
go back to reference Freedman D, Ron E, Ballard-Barbash R et al (2006) Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes (Lond) 30(5):822–829CrossRef Freedman D, Ron E, Ballard-Barbash R et al (2006) Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes (Lond) 30(5):822–829CrossRef
18.
go back to reference Vogel J, Franklin B, Zalesin K (2007) Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery. Am J Cardiol 99(2):222–226CrossRefPubMed Vogel J, Franklin B, Zalesin K (2007) Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery. Am J Cardiol 99(2):222–226CrossRefPubMed
19.
go back to reference Karcz W, Krawczykowski D, Kuesters S et al (2011) Influence of sleeve gastrectomy on NASH and type 2 diabetes mellitus. J Obes 765473 Karcz W, Krawczykowski D, Kuesters S et al (2011) Influence of sleeve gastrectomy on NASH and type 2 diabetes mellitus. J Obes 765473
20.
go back to reference Fabbrini E, Sullivan S, Klein S (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51(2):679–689CrossRefPubMedPubMedCentral Fabbrini E, Sullivan S, Klein S (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51(2):679–689CrossRefPubMedPubMedCentral
21.
go back to reference Dixon J, Bhathal P, Hughes N et al (2004) Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 39(6):1647–1654CrossRefPubMed Dixon J, Bhathal P, Hughes N et al (2004) Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 39(6):1647–1654CrossRefPubMed
22.
go back to reference Chavez-Tapia N, Tellez-Avila F, Barrientos-Gutierrez T et al (2010) Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev 20(1):CD007340 Chavez-Tapia N, Tellez-Avila F, Barrientos-Gutierrez T et al (2010) Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev 20(1):CD007340
23.
go back to reference Mattar S, Velcu L, Rabinovitz M et al (2005) Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 242(4):610–617PubMedPubMedCentral Mattar S, Velcu L, Rabinovitz M et al (2005) Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 242(4):610–617PubMedPubMedCentral
24.
go back to reference Taitano A, Markow M, Finan J et al (2015) Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointest Surg 19(3):429–437CrossRefPubMed Taitano A, Markow M, Finan J et al (2015) Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointest Surg 19(3):429–437CrossRefPubMed
25.
go back to reference Vuppalanchi R, Chalasan N (2009) Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 49(1):306–317CrossRefPubMedPubMedCentral Vuppalanchi R, Chalasan N (2009) Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 49(1):306–317CrossRefPubMedPubMedCentral
26.
go back to reference Aithal G, Thomas J, Kaye P et al (2008) Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology 135(4):1176–1184CrossRefPubMed Aithal G, Thomas J, Kaye P et al (2008) Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology 135(4):1176–1184CrossRefPubMed
27.
go back to reference Mathurin P, Gonzalez F, Kerdraon O et al (2006) The evolution of severe steatosis after bariatric surgery is related to insulin resistance. Gastroenterology 130(6):1617–1624CrossRefPubMed Mathurin P, Gonzalez F, Kerdraon O et al (2006) The evolution of severe steatosis after bariatric surgery is related to insulin resistance. Gastroenterology 130(6):1617–1624CrossRefPubMed
Metadata
Title
Non-alcoholic fatty liver disease resolution following sleeve gastrectomy
Authors
Ardeshir Algooneh
Sulaiman Almazeedi
Salman Al-Sabah
Maha Ahmed
Feras Othman
Publication date
01-05-2016
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 5/2016
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-015-4426-0

Other articles of this Issue 5/2016

Surgical Endoscopy 5/2016 Go to the issue